$0.8601
-0.31-26.49%
Last update: Oct 30, 3:46 PM
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) Stock Price, Quote, News & History
BCLIOTCQB
BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced its voluntary delisting from the...
You can purchase shares of BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI) through any online brokerage.
There are no as such competitors for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
There is no analysis for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. to provide a consensus price target.
The stock price for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is $0.8601 last updated October 30, 2026 at 3:46 PM EDT.
There are no upcoming dividends for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc..
BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Brainstorm Cell Therapeutics Inc is a biotechnology company committed to the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, progressive...
